Nivolumab and ipilimumab (N plus I) is active in patients (pts) with metastatic uveal melanoma (mUM) with extra-hepatic only involvement: Pooled analysis from 2 phase II trials
No Thumbnail Available
Identifiers
Date
2020-09-01
Authors
Piulats Rodriguez, J. M.
Patel, S.
Espinosa, E.
Pelster, M. S.
de la Cruz Merino, L.
Khoja, L. T.
Joshua, A. M.
Tebe, C.
Berrocal, A.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
